These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9396508)

  • 1. Common mutation in the methylenetetrahydrofolate reductase gene offers no support for mild hyperhomocysteinemia being a causal risk factor for cardiovascular disease.
    Brattström L
    Circulation; 1997 Nov; 96(10):3805-7. PubMed ID: 9396508
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR).
    Rozen R
    Thromb Haemost; 1997 Jul; 78(1):523-6. PubMed ID: 9198208
    [No Abstract]   [Full Text] [Related]  

  • 3. [Role of polymorphic variants of the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene in the pathogenesis of cardiovascular diseases].
    Spiridonova MG; Stepanov VA; Puzyrev VP
    Klin Med (Mosk); 2001; 79(2):10-6. PubMed ID: 11419077
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperhomocysteinemia: another independent vascular risk factor.
    Deleu D
    Saudi Med J; 2000 Aug; 21(8):787-8. PubMed ID: 11423902
    [No Abstract]   [Full Text] [Related]  

  • 5. Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population.
    Nair KG; Nair SR; Ashavaid TF; Dalal JJ; Eghlim FF
    J Assoc Physicians India; 2002 May; 50 Suppl():9-15. PubMed ID: 12186157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis.
    Kluijtmans LA; den Heijer M; Reitsma PH; Heil SG; Blom HJ; Rosendaal FR
    Thromb Haemost; 1998 Feb; 79(2):254-8. PubMed ID: 9493571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylenetetrahydrofolate reductase (MTHFR) mutation, homocyst(e)ine, and coronary artery disease.
    Wilcken DE; Wang XL; Wilcken B
    Circulation; 1997 Oct; 96(8):2738-40. PubMed ID: 9355925
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperhomocysteinemia, MTHFR C677T genotype and low folate levels: a risk combination for acute coronary disease in a Portuguese population.
    Araújo F; Lopes M; Gonçalves L; Maciel MJ; Cunha-Ribeiro LM
    Thromb Haemost; 2000 Mar; 83(3):517-8. PubMed ID: 10744169
    [No Abstract]   [Full Text] [Related]  

  • 9. C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients.
    Gemmati D; Serino ML; Trivellato C; Fiorini S; Scapoli GL
    Haematologica; 1999 Sep; 84(9):824-8. PubMed ID: 10477457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of MTHFR 677C-->T missense mutation, total plasma homocysteine levels and associated risk factors in Malay subjects.
    Ling KH; Rosli R; Duraisamy G; Nasir MT
    Med J Malaysia; 2003 Jun; 58(2):243-54. PubMed ID: 14569745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C677T methylenetetrahydrofolate reductase polymorphism influences the homocysteine-lowering effect of hormone replacement therapy.
    Brown CA; McKinney KQ; Young KB; Norton HJ
    Mol Genet Metab; 1999 May; 67(1):43-8. PubMed ID: 10329022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylenetetrahydrofolate reductase (MTHFR) C677T mutation in Turkish patients with thrombosis.
    Balta G; Gürgey A
    Turk J Pediatr; 1999; 41(2):197-9. PubMed ID: 10770658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the relationship between methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine level in pregnancy induced hypertension patients].
    Li K; Sun Y; Chen L
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):205-7. PubMed ID: 11776159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Homocysteine, methylenetetrahydrofolate reductase/C677T genotype and risk for coronary heart disease. The AtheroGene study].
    Blankenberg S; Rupprecht HJ; Peetz D; Bickel C; Hofman KP; Tiret L; Meyer J
    Dtsch Med Wochenschr; 2002 Apr; 127(14):729-35. PubMed ID: 11935469
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hyperhomocysteinemia and C677T mutation of methylenetetrahydrofolate reductase].
    Grasa Ullrich JM; Torres Gómez M; Sánchez Marín B; Calvo Martín MT; García Erce JA; Giralt Raichs M
    An Med Interna; 2002 May; 19(5):269. PubMed ID: 12108010
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular biology of 5,10-methylenetetrahydrofolate reductase.
    Födinger M; Hörl WH; Sunder-Plassmann G
    J Nephrol; 2000; 13(1):20-33. PubMed ID: 10720211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of factor V (FV) Leiden and C677T methylenetetrahydrofolate reductase (MTHFR) mutations in Colombians.
    Camacho Vanegas O; Giusti B; Restrepo Fernandez CM; Abbate R; Pepe G
    Thromb Haemost; 1998 Apr; 79(4):883-4. PubMed ID: 9569213
    [No Abstract]   [Full Text] [Related]  

  • 18. The C677T thermolabile variant of methylene tetrahydrofolate reductase on homocysteine, folate and vitamin B12 in a hemodialysis center.
    Trimarchi H; Genoud V; Schiel A; Castañon M; Freixas E; Diaz ML; Schropp J; Martino D; Pereyra H; Kordich L
    Medicina (B Aires); 2002; 62(2):149-53. PubMed ID: 12038037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification.
    Goyette P; Sumner JS; Milos R; Duncan AM; Rosenblatt DS; Matthews RG; Rozen R
    Nat Genet; 1994 Jun; 7(2):195-200. PubMed ID: 7920641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine and cardiovascular risk.
    Scott JM
    Am J Clin Nutr; 2000 Aug; 72(2):333-4. PubMed ID: 10919922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.